The start of 2021 has been rocky for Britain. Its exit from the European Union unleashed a colossal amount of red tape that has left some industries desperate for help, and the country is under yet another lockdown because of a fast-spreading strain of the coronavirus.
But there has been a glimmer of hope. More than four million people in Britain have been partly vaccinated against the coronavirus, a promising pace of inoculation.
Investors looking to ride a wave of optimism about a vaccine rollout have turned to Britain’s stock market, which has posted a strong start to the year, jumping more than 6 percent in the first week.
In the first two and a half weeks of January, the FTSE 100, Britain’s benchmark stock index of large companies, gained 4.3 percent — outstripping the S&P 500 index, which rose 2.6 percent, and the Stoxx Europe 600 index, which was up 3 percent. Even when the gains are converted to U.S. dollars, the FTSE 100 still has a clear lead.
Beyond the vaccine rollout’s helping to ensure an economic rebound, another factor is drawing investors: the relative cheapness of British stocks.
The FTSE 100 index is benefiting from an investment strategy in which traders buy so-called value stocks. These are companies that are perceived to be trading below their true value because their business has been disrupted by a recession, especially in the financial and energy sectors, and the FTSE 100 has a large share of these stocks.
Analysts at Citigroup have ordained Britain’s stock market their “favorite” value trade.
“I would emphasize the very much unloved and horrible dreadful U.K. market might be worth a look this year,” Robert Buckland, a Citigroup equity strategist, said in a presentation last week. “We all know it’s been a place to avoid for many, many years.”
The British stock market has been a laggard for years. The last time the FTSE’s gains looked better than those of the American and European benchmarks was in 2016, when a severe drop in the pound enhanced the earnings of FTSE 100 companies, which earn three-quarters of their revenue overseas.
Once converted into dollars, the annual returns of the FTSE 100 have been the worst of the three indexes for the past nine years.
Why are investors betting on a turnaround now? For one thing, many of them are ready for a bargain. The equity bull market has been dominated by shares of American tech companies that are expensive, which makes some investors nervous about how much they can keep rising. Cheap stocks in industries that tend to do well during economic boom times are offering an alternative.
And then there is Britain’s free-trade deal with the European Union. Some investors have put aside whether it’s a good or bad deal in its detail, in favor of relief that an agreement was finally reached in late December.
The deal “reduced that overhang people had of uncertainty,” said Caroline Simmons, the U.K. chief investment officer at UBS Global Wealth Management, the Swiss asset management firm. And it could encourage the return of overseas investors that were put off by Brexit, she said. Until last week, UBS said British stocks were one of its most preferred trades, for the first time since 2013.
Two asset managers at London-based Schroders are hoping the interest in large companies will trickle down to smaller ones, which are lagging. Rory Bateman and Tim Creed raised 75 million pounds ($102 million) in December for their British Opportunities Trust, a fund that will invest in public and private companies that have been hit by the pandemic but that they expect to recover with a little extra capital.
The vaccines were the “start of the turn in sentiment around the U.K.,” Mr. Bateman said. “Momentum is definitely shifting.”
But this strategy is highly dependent on the success of the vaccine rollout and could easily be undone by signs of delays in manufacturing or distribution. And Britain’s equity index could slip back down to the bottom of the pile.
